Eli Lilly confirms October 29 results. Eli Lilly stock trades 1.79 percent below its high
Published on 10/20/2026 at 11:44 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSUpcoming results and valuation
- Eli Lilly confirmed third-quarter results for October 29, 2026, in a release dated October 15, 2026.
- The company's market capitalization was EUR 1,052.1 billion as of October 20, 2026.
- Eli Lilly stock trades at EUR 1,117.40 at 11:38 a.m. CEST at Lang & Schwarz on October 20, 2026, 0.52 percent above the Xetra close of October 19, 2026.
Eli Lilly (ISIN US5324571083) was trading at EUR 1,117.40 at Lang & Schwarz on October 20, 2026, 1.79 percent below its 52-week high of EUR 1,137.80. Eli Lilly and Company confirmed on October 15, 2026, that it will announce third-quarter results on October 29, 2026.
October 29 is the next test
The upcoming report gives the valuation a near-term test because the stock sits only 1.79 percent below its 52-week high. The company also scheduled a conference call for 10:00 a.m. Eastern time on October 29, 2026, according to the release.
The latest reported market picture puts Eli Lilly's capitalization at EUR 1,052.1 billion as of October 20, 2026. Its 52-week range runs from EUR 685.50 to EUR 1,137.80, leaving the current quote EUR 20.40 below the upper end.
What does the valuation imply?
The immediate investor question is whether the next report can support a price already near its yearly peak. At Lang & Schwarz, the stock was EUR 5.80 above the Xetra close of October 19, 2026, equal to a calculated gain of 0.52 percent.
The price action is measured rather than directional enough to define the session on its own. That makes the October 29 results date the clearest scheduled company catalyst in the current calendar.
Two dates for the calendar
Eli Lilly and Company lists the third-quarter 2026 earnings call for October 29, 2026, at 10:00 a.m. EDT and Lilly Innovation Day for December 7, 2026, from 9:00 a.m. to 1:00 p.m. EST.
Stock remains near its yearly high
The reference picture is clear: a EUR 1,117.40 quote, a EUR 1,137.80 52-week high, and a EUR 1,052.1 billion market capitalization. The next material company date is October 29, 2026.
The stock was trading at EUR 1,117.40 at Lang & Schwarz on October 20, 2026, at 11:38 a.m. CEST, plus 0.52 percent versus the Xetra close of October 19, 2026 at EUR 1,111.60. The further course of trading is shown by the continuously updated real-time quote of Eli Lilly stock.
Eli Lilly stock facts
- Company: Eli Lilly and Company
- ISIN: US5324571083
- Ticker: LLY
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 20, 2026, 11:38 a.m. CEST): EUR 1,117.40
- Change versus Xetra close: plus 0.52 percent
- Xetra close (October 19, 2026): EUR 1,111.60
- Market capitalization: EUR 1,052.1 billion (as of October 20, 2026)
- 52-week range: EUR 685.50-1,137.80 (as of October 20, 2026)
Market context: Market report S&P 500.
